- Home
- SNX vs EXAS Comparison
SNX vs EXAS Comparison
Compare SNX & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- EXAS
- Stock Information
- Founded
- SNX 1980
- EXAS 1995
- Country
- SNX United States
- EXAS United States
- Employees
- SNX N/A
- EXAS N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- EXAS Medical Specialities
- Sector
- SNX Technology
- EXAS Health Care
- Exchange
- SNX Nasdaq
- EXAS Nasdaq
- Market Cap
- SNX 13.3B
- EXAS 11.0B
- IPO Year
- SNX 2003
- EXAS N/A
- Fundamental
- Price
- SNX $153.10
- EXAS $101.55
- Analyst Decision
- SNX Strong Buy
- EXAS Buy
- Analyst Count
- SNX 10
- EXAS 20
- Target Price
- SNX $169.00
- EXAS $76.38
- AVG Volume (30 Days)
- SNX 558.5K
- EXAS 9.3M
- Earning Date
- SNX 01-09-2026
- EXAS 11-03-2025
- Dividend Yield
- SNX 1.15%
- EXAS N/A
- EPS Growth
- SNX 18.98
- EXAS N/A
- EPS
- SNX 9.21
- EXAS N/A
- Revenue
- SNX $60,973,509,000.00
- EXAS $3,082,033,000.00
- Revenue This Year
- SNX $7.25
- EXAS $16.68
- Revenue Next Year
- SNX $4.50
- EXAS $12.36
- P/E Ratio
- SNX $16.58
- EXAS N/A
- Revenue Growth
- SNX 6.94
- EXAS 14.47
- 52 Week Low
- SNX $92.23
- EXAS $38.81
- 52 Week High
- SNX $167.76
- EXAS $101.87
- Technical
- Relative Strength Index (RSI)
- SNX 53.22
- EXAS 91.30
- Support Level
- SNX $142.22
- EXAS $66.00
- Resistance Level
- SNX $151.27
- EXAS $101.26
- Average True Range (ATR)
- SNX 3.94
- EXAS 2.98
- MACD
- SNX 0.37
- EXAS 3.32
- Stochastic Oscillator
- SNX 85.46
- EXAS 99.12
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.